Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
about
Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry[Pediatric intracranial tumors : Principles of diagnostics and treatment].The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic reviewComparison of survival between the UK and US after surgery for most common pediatric CNS tumors.Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study.Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) databaseInsulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.Advances in paediatric cancer treatmentEarly treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade gliomaMetastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital.TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach.Targeted therapy in pediatric low-grade glioma.Advances in the management of low-grade gliomas.Optic pathway gliomas: a review.Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.Efficacy of Stereotactic Conformal Radiotherapy vs Conventional Radiotherapy on Benign and Low-Grade Brain Tumors: A Randomized Clinical Trial.Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.Low-grade gliomas in children: single institutional experience in 198 cases.Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final reportMortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.Pediatric low-grade gliomas: implications of the biologic era.Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.Pseudoprogression in pediatric low-grade glioma after irradiation.Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium.Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.
P2860
Q30245146-33802A16-5C9A-4F78-8F9B-2FE2596D374BQ30420487-2F4ACEB9-21A1-4D50-9467-8F55207305EBQ30839975-B1CA4DAD-6EB7-4EE5-BC45-4749A0DC826FQ30847046-94B5EF40-BB3D-482F-AA99-08D8D2B01A11Q33894483-447E93B5-C946-4955-B08C-B0D9B00AAA4DQ34342321-C12776E5-E06F-4503-B429-F337FA29FD99Q34354839-B96A914C-84A3-4D68-BBD6-15736D7E2A36Q35670831-25346542-BCB9-4BEA-9F3D-E16267CF0CD5Q35754390-36977C81-22BF-455B-9556-A5ECF6648003Q35815306-601508C4-FF24-4B50-8818-83563BAF48FBQ36311369-C03EFAB3-FC72-4189-A059-4BB089E4E1B0Q36377476-F28E1F89-CB4F-4203-9C1C-53694243222CQ36508630-5D2D4D41-1A4C-4784-8B25-575049283D0BQ36706889-3DC9DACD-268E-44AA-8BB5-D6F646B4F470Q36968257-B53B378D-924A-4D97-AFF1-90EF3EE93C74Q37055286-20D6D1EA-E907-45C9-B916-FD5EF12DF26AQ37366167-FBB8F2C9-5457-402C-9DDC-0E4BEF074C9CQ37439330-94BAB4B3-3CDD-4F57-A737-6B66B156E833Q37565322-CC4F3FC0-C362-40B5-99AD-848E9AA8FADCQ37706929-B1B77AB8-ED15-4D25-91AD-0EA226F0BBD3Q38161853-16680086-F940-40A7-BDFA-A3467C53F769Q38194055-0A8B2115-024E-45F2-955D-24089C80AFBCQ38219898-4FB2FDAE-AC2C-41E5-A7B4-C42A324D934FQ38233447-2975AC98-1BD6-4710-8130-2C2216500FE9Q38315617-F795401F-3590-45FC-97B2-F4FB0EE509E2Q38376138-26DF9C73-0B25-4502-9DB6-4D7FB9151113Q38426566-F1D8E687-75C2-4AA2-A956-5AA9FC5C13E5Q38544218-EF9A1B54-CCD0-473F-8681-5D58CE1879D6Q38559372-F8F8423B-8FD3-419D-83F7-F984372547EBQ38661348-B49E251B-4C44-4660-B8FA-CDE04091C06BQ38666920-9AD63862-00B6-42D9-8F6B-A46C122526C1Q38679142-78E56EBC-1A63-48F7-8CA1-94DCCD1ACEE8Q38816560-9100D8C1-52C6-42CF-AC83-98568B13EE44Q38962187-A555D2D3-72DA-4CCE-8A44-BFE854F2A5ABQ39200135-C99CB1B5-FEF8-443E-B027-30B76B7A19FEQ40104521-EAB69DCB-9D70-4569-8681-2F56B7B70092Q40636040-9C43D3B8-39B9-4C50-A27B-DE152E6B56EDQ40857380-F7BE19C5-5354-4BF1-9331-676F38E3068DQ40945899-092C4B18-2223-42A5-BCB9-7B3FEF53F6BFQ41458198-ADCEA529-9847-4AF8-8C12-5F983036C126
P2860
Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@ast
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@en
type
label
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@ast
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@en
prefLabel
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@ast
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@en
P2093
P2860
P356
P1433
P1476
Long-term follow-up of the mul ...... atric Oncology and Hematology.
@en
P2093
Andreas Faldum
Astrid K Gnekow
Brigitte Bison
Fabian Falkenstein
Isabella Zwiener
Niels Soerensen
Pablo Hernáiz Driever
Rolf-D Kortmann
Susanne Berkefeld
Torsten Pietsch
P2860
P304
P356
10.1093/NEUONC/NOS202
P577
2012-08-31T00:00:00Z